Specialist oncological surgery for removal of the ovaries and fallopian tubes in brca1 and brca2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels

New surveillance guidelines for li-fraumeni and hereditary tp53 related cancer syndrome: implications for germline tp53 testing in breast cancer

Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers

High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer

Constitutional de novo deletion cnv encompassing rest predisposes to diffuse hyperplastic perilobar nephroblastomatosis (hpln)

Tp53, a gene for colorectal cancer predisposition in the absence of li-fraumeni-associated phenotypes

Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors

Brca1 and brca2 pathogenic variant carriers and endometrial cancer risk: a cohort study

Germline tp53 testing in breast cancers: why, when and how?

Assessment of mismatch repair deficiency in ovarian cancer